Literature DB >> 20562519

Functional analysis of human organic cation transporter OCT3 (SLC22A3) polymorphisms.

Takeshi Sakata1, Naohiko Anzai, Toru Kimura, Daisaku Miura, Toshiyuki Fukutomi, Michio Takeda, Hiroyuki Sakurai, Hitoshi Endou.   

Abstract

We analyzed the functional properties of five single nucleotide polymorphisms (SNPs) in organic cation transporter OCT3 gene (SLC22A3) resulting in the amino acid changes with a transient expression system. Three SNPs (A116S, T400I, and A439V) exhibited reduced uptake of both [(3)H]histamine and [(3)H]MPP(+), although their protein expressions were detected in the plasma membrane of transfected cells. This study suggests that the OCT3 variants will contribute to inter-individual variations leading to the differences in cationic drug disposition as well as certain disease processes such as hypertension, allergic diseases, and neuropsychiatric diseases by the clearance of endogenous organic cations such as biogenic amines.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20562519     DOI: 10.1254/jphs.09331sc

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  17 in total

Review 1.  OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies.

Authors:  Megan Roth; Amanda Obaidat; Bruno Hagenbuch
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 2.  Pharmacogenetic studies update in type 2 diabetes mellitus.

Authors:  Shalini Singh; Kauser Usman; Monisha Banerjee
Journal:  World J Diabetes       Date:  2016-08-10

3.  Functional organic cation transporters mediate osteogenic response to metformin in human umbilical cord mesenchymal stromal cells.

Authors:  Faisal E Al Jofi; Tao Ma; Dong Guo; Monica P Schneider; Yan Shu; Hockin H K Xu; Abraham Schneider
Journal:  Cytotherapy       Date:  2018-03-16       Impact factor: 5.414

4.  Prediction and validation of enzyme and transporter off-targets for metformin.

Authors:  Sook Wah Yee; Lawrence Lin; Matthew Merski; Michael J Keiser; Aakash Gupta; Youcai Zhang; Huan-Chieh Chien; Brian K Shoichet; Kathleen M Giacomini
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-09-03       Impact factor: 2.745

5.  Targeting OCT3 attenuates doxorubicin-induced cardiac injury.

Authors:  Kevin M Huang; Megan Zavorka Thomas; Tarek Magdy; Eric D Eisenmann; Muhammad Erfan Uddin; Duncan F DiGiacomo; Alexander Pan; Markus Keiser; Marcus Otter; Sherry H Xia; Yang Li; Yan Jin; Qiang Fu; Alice A Gibson; Ingrid M Bonilla; Cynthia A Carnes; Kara N Corps; Vincenzo Coppola; Sakima A Smith; Daniel Addison; Anne T Nies; Ralf Bundschuh; Taosheng Chen; Maryam B Lustberg; Joanne Wang; Stefan Oswald; Moray J Campbell; Pearlly S Yan; Sharyn D Baker; Shuiying Hu; Paul W Burridge; Alex Sparreboom
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-02       Impact factor: 11.205

6.  Evaluation of genetic variations in organic cationic transporter 3 in depressed and nondepressed subjects.

Authors:  Nina Hengen; Mitsi H Lizer; Robert S Kidd
Journal:  ISRN Pharmacol       Date:  2011-08-14

7.  Clinical and functional characterization of URAT1 variants.

Authors:  Velibor Tasic; Ann Marie Hynes; Kenichiro Kitamura; Hae Il Cheong; Vladimir J Lozanovski; Zoran Gucev; Promsuk Jutabha; Naohiko Anzai; John A Sayer
Journal:  PLoS One       Date:  2011-12-16       Impact factor: 3.240

8.  Upregulated SLC22A3 has a potential for improving survival of patients with head and neck squamous cell carcinoma receiving cisplatin treatment.

Authors:  Cheng-Ming Hsu; Pai-Mei Lin; Jan-Gowth Chang; Hsin-Ching Lin; Shau-Hsuan Li; Sheng-Fung Lin; Ming-Yu Yang
Journal:  Oncotarget       Date:  2017-09-04

9.  PHACTR1 and SLC22A3 gene polymorphisms are associated with reduced coronary artery disease risk in the male Chinese Han population.

Authors:  Qingbin Zhao; Huiyi Wei; Dandan Liu; Baolan Shi; Lei Li; Mengdan Yan; Xiyang Zhang; Fengjiao Wang; Yongri Ouyang
Journal:  Oncotarget       Date:  2017-01-03

10.  Organic Cation Transporters in Psychiatric Disorders.

Authors:  Lynette C Daws
Journal:  Handb Exp Pharmacol       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.